Shots:

• Innovent to receive milestones for development and commercialization along with royalties on net sales of the therapy in the licensed territory. Etana is committed to launch Byvasda in Indonesia
• The collaboration will enable Byvsada to penetrate into a Southeast Asian market and allow Innovent to bolster its presence globally
• In Jan’2020- Innovent signed an out-license agreement with Coherus to commercialize the biosimilar in the US & Canada

 ­ Ref: PRNewswire | Image: Innovent Bio